Studies with aspirin have shown it can inhibit growth and decrease the invasiveness of breast cancer. In specific, a February 2010 study published in the Journal of Clinical Oncology examined whether aspirin use among women with breast cancer would decrease their risk of death from breast cancer. The study included over 4,000 registered nurses in the Nurses' Health Study who were diagnosed with stages I, II, or III breast cancer between 1976 and 2002 and were observed until death or June 2006. Results found that 2-7 days of aspirin use per week was associated with both a decrease in breast cancer metastasis and death from breast cancer.
For more information about this study, link to the Journal of Clinical Oncology here: http://jco.ascopubs.org/cgi/content/abstract/JCO.2009.22.7918v1
No comments:
Post a Comment